Originally developed for type 2 diabetes, the GLP-1 class has been extensively studied for weight management
A third phenotypic variant, the gray phenotype has recently been identified [229]
Patients who self-administer without training may inject at incorrect depths, fail to properly sanitize the injection site, or reuse needles, all of which increase the risk of complications
Discuss with a pharmacist or clinician before using retinoid products, which should be avoided during pregnancy and breastfeeding
Dipeptidyl peptidase-4 inhibitor use is associated with decreased risk of fracture in patients with type 2 diabetes: a population-based cohort study
This distinction matters enormously in the current regulatory environment, which we will cover in detail later